Skip to main content
SpringerLink
Log in

Metformin does not increase cardiovascular events in patients with CVD

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Li T, et al. Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases Drugs : 15 Jan 2022. Available from: URL: https://doi.org/10.1007/s40265-021-01665-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Metformin does not increase cardiovascular events in patients with CVD. Reactions Weekly 1891, 9 (2022). https://doi.org/10.1007/s40278-022-09261-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09261-6

Search

Navigation